{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-030433","form_type":"8-K","ticker":"CBRRF","cik":"0001845149","company_name":"Chain Bridge I","filed_at":"2025-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.108788+00:00","generated_at":"2026-05-23T17:29:04.621122+00:00","sec_items":["1.02","4.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Chain Bridge I terminates Phytanix Bio merger agreement; appoints RBSM as new auditor","bullets":["Mutual termination of Business Combination Agreement with Phytanix Bio effective April 7, 2025.","Frank, Rimerman dismissed as independent auditor on April 4, 2025; RBSM engaged for fiscal 2024.","Unaudited Q3 2024 financials to be restated due to $200,000 understatement of promissory note liability.","Material weakness in internal controls over financial reporting identified as of September 30, 2024.","Company working to file amended Form 10-Q and Form 10-K for fiscal 2024 with RBSM."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-030433","json":"https://secwatch.observer/filing/0001213900-25-030433.json","markdown":"https://secwatch.observer/filing/0001213900-25-030433.md","text":"https://secwatch.observer/filing/0001213900-25-030433.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845149/000121390025030433/0001213900-25-030433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845149/000121390025030433/ea0237763-8k_chain1.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T17:29:04.621122+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}